Arcadia Investment Management’s AstraZeneca AZN Stock Holding History

Arcadia Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-111	Closed	-$17.3K	–	262
2024 Q2	$17.3K	Hold	111	–	–	﹤0.01%	247
2024 Q1	$15K	Hold	111	–	–	﹤0.01%	258
2023 Q4	$15K	Hold	111	–	–	﹤0.01%	268
2023 Q3	$15K	Hold	111	–	–	﹤0.01%	270
2023 Q2	$15.9K	Hold	111	–	–	﹤0.01%	283
2023 Q1	$15.4K	Hold	111	–	–	﹤0.01%	296
2022 Q4	$15.1K	Buy	+111	New	+$13.9K	﹤0.01%	292
2021 Q1	–	Sell	-800	Closed	-$80K	–	281
2020 Q4	$80K	Hold	800	–	–	0.02%	157
2020 Q3	$88K	Buy	+800	New	+$89K	0.02%	156

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return